CHAD Board Nominees Reelected.Business Editors CHATSWORTH, Calif.--(BUSINESS WIRE)--Sept. 12, 2002 CHAD Therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. , Inc. (AMEX AMEX See: American Stock Exchange :CTU CTU Colorado Technical University CTU Czech Technical University in Prague CTU Counter Terrorist Unit CTU Clinical Trials Unit CTU Catholic Theological Union CTU Chicago Teachers Union CTU Computer Training Unit CTU Control Unit ) announced the results of voting for the Board of Directors elections at the 2002 Annual Meeting of Shareholders that was held on September 11, 2002. There were 8,387,374 shares represented at the meeting out of total of 10,068,032 outstanding shares. There were four seats on the Board up for election and each of the four persons nominated by the CHAD Board of Directors, John C. Boyd, Norman Cooper, Thomas Cooper, Thomas, 1759–1839, American scientist, educator, and political philosopher, b. London, educated at Oxford. His important works include Political Essays (1799); the appendixes to the Memoirs of Dr. Joseph Priestley (2 vol. E. Jones and Earl L. Yager, was reelected by a wide margin. A group of dissident shareholders dissident shareholders Shareholders who oppose a firm's management or management policy. For example, dissident shareholders of Hewlett-Packard opposed that firm's offer to purchase Compaq Computer. and others had waged a proxy contest Proxy contest A battle for the control of a firm in which a dissident group seeks, from the firm's other shareholders, the right to vote those shareholders' shares in favor of the dissident group's slate of directors. Also called proxy fights. in an attempt to elect their own nominees to the CHAD Board of Directors. This group, which had reported that they owned 722,000 shares, apparently only received proxies for an additional 30,021 shares in support of their candidates. Thomas E. Jones, CHAD's Chief Executive Officer, stated, "We are very pleased with the results of the election and would like to thank our shareholders for their support. We pledge to continue with our strategy to enhance shareholder value through sound business practices and the continued development of quality products that meet the needs of our customers and their home oxygen patients. We are seeking to increase the market share for our current product lines and we will continue to explore new opportunities and technologies which may expand and broaden our product lines." |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion